FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Taro Pharmaceuticals U.S.A. Best Choice Recall

Best Choice, Clotrimazole Cream, USP 1%, Antifungal

Taro Pharmaceuticals U.S.A., Inc. · Hawthorne, NY

Risk level
Class II
Reported by FDA
Dec 23, 2020
Recall ID
D-0157-2021
Check your lot numberHow we source this data

Summary

Taro Pharmaceuticals U.S.A. recalled Best Choice starting Nov 17, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0157-2021 on Dec 23, 2020. Reason: Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Product description

Best Choice, Clotrimazole Cream, USP 1%, Antifungal, NET WT 0.5 OZ (14.2g), Distributed by: Valu Merchandisers, CO . 5000 Kansas Ave. Kansas City, KS 66106 Made in Canada. UPC 0-70038-20355-1

Lot numbers, UPCs & expiration codes

Lot #: D867331087, Exp Mar, 2021 70,200 63,252

Where it was sold

Distributed Nationwide in the USA and Canada

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0157-2021
Classification
Class II
Status
Terminated
Recall initiated
Nov 17, 2020
FDA report date
Dec 23, 2020
Quantity
11,088 1 oz tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.

Original FDA data

Every field from FDA enforcement report D-0157-2021, exactly as published.

Show all FDA fields
City
Hawthorne
State
NY
Status
Terminated
Country
United States
Event ID
86833
Address
3 Skyline Dr
Code information
Lot #: D867331087, Exp Mar, 2021 70,200 63,252
Postal code
10532-2174
Report date
Dec 23, 2020
Product type
Drugs
Recall number
D-0157-2021
Classification
Class II
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.
Product quantity
11,088 1 oz tubes
Termination date
Feb 21, 2024
Reason for recall
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Best Choice, Clotrimazole Cream, USP 1%, Antifungal, NET WT 0.5 OZ (14.2g), Distributed by: Valu Merchandisers, CO . 5000 Kansas Ave. Kansas City, KS 66106 Made in Canada. UPC 0-70038-20355-1
Distribution pattern
Distributed Nationwide in the USA and Canada
Recall initiation date
Nov 17, 2020
Initial firm notification
Letter
Center classification date
Dec 16, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0157-2021, published Dec 23, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls